Results 231 to 240 of about 155,011 (286)

Personalizing smoking cessation pharmacotherapy using neuroaffective reactivity profiles: A randomized controlled trial

Addiction, EarlyView.
Abstract Background and aims By assessing neuroaffective response to motivationally relevant cues before a quit attempt, we have shown that smokers who attribute greater incentive salience to cigarette‐related cues than non‐cigarette‐related rewards (Sign‐trackers, ST) benefit more from varenicline compared with smokers with the opposite neuroaffective
Francesco Versace, Charles E. Green, Yong Cui, Jason D. Robinson, Menton M. Deweese, Jennifer A. Minnix, George Kypriotakis, Seokhun Kim, Maher Karam‐Hage, Paul M. Cinciripini   +9 more
wiley   +1 more source

The Human Alpha3 Beta2 Neuronal Nicotinic Acetylcholine Receptor Can Form Two Distinguishable Subtypes. [PDF]

Int J Mol Sci
Jackson DC, Hall MK, Sudweeks SN.
europepmc   +1 more source

Decline of phosphatidylethanol (B‐PEth) during abstinence in patients with alcohol use disorder undergoing withdrawal treatment, and the correlation of B‐PEth with self‐reported alcohol intake

Addiction, EarlyView.
Abstract Background and aim Accurately estimating alcohol consumption is crucial for clinical decision‐making and monitoring treatment outcomes. Phosphatidylethanol in blood (B‐PEth), a direct alcohol biomarker, is currently the most reliable indicator of alcohol intake, with a detection window of several weeks; however, the factors influencing the ...
Andrea de Bejczy, Lisa Walther, Cecilia Nilsson‐Wallmark, Barbro Askerup, Anders Isaksson   +4 more
wiley   +1 more source

Editorial Perspective: Smoking, vaping and mental health - a perspective on potential causal mechanisms. [PDF]

J Child Psychol Psychiatry
Treur JL, Vermeulen JM, van de Weijer MP.   +2 more
europepmc   +1 more source

Associations of cannabis use, tobacco use and co‐use with brain volume: A systematic review and meta‐analysis

Addiction, EarlyView.
Abstract Background and aims Cannabis is the most widely used illicit drug worldwide and is often co‐used with tobacco, the leading cause of preventable death. Although cannabis and tobacco have distinct neurobiological actions, their associations with brain volumes are unclear.
Katherine Sawyer, Tom P. Freeman, Martine Skumlien, Esther Walton, Thomas Lancaster, Jorien L. Treur, Valentina Lorenzetti, Anna K. M. Blackwell, Chloe Burke, Richie J. Carr, Constantinos Constantinides, Maisie Cox, Sarah Dance, Shadi Daryan, Sorcha Hamilton, Tom Jenkins, Gemma M. J. Taylor   +16 more
wiley   +1 more source

The Biological and Prognostic Implications of the Nicotinic Acetylcholine Receptor α3, α5, and α7 Subunits in Oral Squamous Cell Carcinoma. [PDF]

Cancer Med
Lin CM, Lin LW, Chen TC, Ye YL, Chiang BL.   +4 more
europepmc   +1 more source

Determining the impact of cannabis use on tobacco cessation: Results from a prospective non‐randomized tobacco treatment trial

Addiction, EarlyView.
Abstract Background and aims Tobacco‐cannabis co‐use is associated with increased psychosocial and health harms; however, the treatment literature assessing the impact of co‐use has been mixed and suffers from critical limitations. To date, no prospective studies have evaluated the degree to which cannabis co‐use affects tobacco cessation, nor are ...
Erin A. McClure, Nathaniel Baker, Rachel L. Tomko, Kyle J. Walters, Elizabeth Chapman, Matthew J. Carpenter, Kevin M. Gray   +6 more
wiley   +1 more source

Cholinergic signaling modulates intestinal pathophysiology in a Drosophila model of cystic fibrosis. [PDF]

PLoS Genet
Lane EA, Petsakou A, Liu Y, Chen W, Qadiri M, Hu Y, Perrimon N.   +6 more
europepmc   +1 more source

New Chlormequat-Based Ionic Liquids as Plant Resistance Inducers. [PDF]

Molecules
Kukawka R, Spychalski M, Czerwoniec P, Hasiów-Jaroszewska B, Stępniewska-Jarosz S, Frydrych-Tomczak E, Smiglak M.   +6 more
europepmc   +1 more source